OPIANT PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Santa Monica, CA
SEC filing record 1 source field available
Fiscal year end
31 December
OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

SEC filing history

Showing 376-400 of 545 matching filings.

Per page
25
Current page
16
4

OWNERSHIP DOCUMENT

Filing date
31 Aug 2017
Reporting date
29 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Aug 2017
Reporting date
29 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
29 Aug 2017
Reporting date
29 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38193

DEFA14A

Filing date
29 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

FORM 8-K

Filing date
29 Aug 2017
Reporting date
28 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CERTNAS File 001-38193

AUTO-GENERATED PAPER DOCUMENT

Filing date
28 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
28 Aug 2017
Reporting date
28 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-38193

8-A12B

Filing date
25 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
11 Aug 2017
Reporting date
11 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
10 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-55330

DEF 14A

Filing date
27 Jul 2017
Reporting date
31 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-55330

PRE 14A

Filing date
29 Jun 2017
Reporting date
29 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
28 Jun 2017
Reporting date
22 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
27 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
02 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

8-K

Filing date
30 May 2017
Reporting date
26 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

FORM 8-K

Filing date
19 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

FORM 8-K

Filing date
19 Apr 2017
Reporting date
18 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

FORM 8-K

Filing date
18 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

FORM 8-K

Filing date
06 Apr 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-55330

CT ORDER filing

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55330

FORM 8-K

Filing date
16 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .